Expert Panel Gives Nod to Oxford Vaccine in India for Emergency Use

New Delhi: A day before commencement  of dry run for vaccination, the expert panel at the Central Drugs Standard Control Organization (CDSCO) has given a conditional approval to the Covid-19 vaccine developed by AstraZeneca and Oxford University for emergency use today, reports said.

According to reports, more than 5 crore doses of the AstraZeneca vaccine have already been stockpiled by its local manufacturer, Serum Institute of India (SII).

Comments are closed.